Mulugeta Million Selected Research

cortagine

1/2015	Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.
7/2009	Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mulugeta Million Research Topics

Disease

7	Hyperalgesia 01/2019 - 09/2003
5	Hypersensitivity (Allergy) 01/2015 - 09/2005
3	Body Weight (Weight, Body) 10/2017 - 01/2016
3	Diarrhea 01/2015 - 07/2009
3	Visceral Pain 09/2005 - 10/2004
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015 - 01/2002
2	Inflammation (Inflammations) 01/2014 - 03/2013
2	Ulcerative Colitis 03/2013 - 11/2012
2	Cushing Syndrome 02/2011 - 03/2010
2	Atrophy 02/2011 - 03/2010
1	Neuroinflammatory Diseases 10/2017
1	Encephalitis (Encephalitis, Rasmussen) 10/2017
1	Obesity 10/2017
1	Hyperemia 04/2015
1	Hypotension (Low Blood Pressure) 04/2015
1	Colitis 01/2014
1	Alopecia (Baldness) 02/2011
1	Ileus 09/2003
1	Ganglion Cysts (Ganglion) 05/2002

Drug/Important Bio-Agent (IBA)

7	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 03/2013 - 01/2002
4	CRF receptor type 1IBA 01/2015 - 09/2003
3	CorticosteroneIBA 01/2017 - 03/2010
3	Corticotropin-Releasing HormoneIBA 01/2015 - 04/2008
3	astressinIBA 07/2009 - 05/2002
2	astressin BIBA 01/2019 - 02/2011
2	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 01/2015
2	Blood Glucose (Blood Sugar)IBA 10/2017 - 01/2016
2	cortagineIBA 01/2015 - 07/2009
2	CRF receptor type 2IBA 03/2013 - 07/2005
2	CP 154526IBA 04/2008 - 05/2002
1	tocinoic acidIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Cholecystokinin (Pancreozymin)IBA 10/2017
1	8-sulfocholecystokinin octapeptideIBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	fluorescein isothiocyanate dextranIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	16S Ribosomal RNAIBA 01/2017
1	EnzymesIBA 01/2017
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2015
1	ProstaglandinsIBA 04/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2015
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 01/2014
1	(VIP-neurotensin) hybrid antagonistIBA 01/2014
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2014
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014
1	PG 97-269IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2014
1	Drinking WaterIBA 01/2014
1	N- (1- ethylpropyl)- (3- methoxy- 5- (2- methoxy- 4- trifluoromethoxyphenyl)- 6- methyl- pyrazin- 2- yl)amineIBA 01/2013
1	5- (6- isopropyl- 2- methylaminopyridin- 3- yl)- (N- (1- ethyl)propyl)- 3- methoxy- 6- methylpyrazine- 2- amineIBA 01/2013
1	Messenger RNA (mRNA)IBA 11/2012
1	Pharmaceutical PreparationsIBA 02/2011
1	Minoxidil (Rogaine)FDA LinkGeneric 02/2011
1	GlucocorticoidsIBA 03/2010
1	Bethanechol (Duvoid)FDA LinkGeneric 01/2010
1	Leu(31)-Pro(34)- neuropeptide Y (NY-LP)IBA 01/2010
1	BIIE 0246IBA 01/2010
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 01/2010
1	Gonadal Steroid Hormones (Sex Hormones)IBA 09/2005
1	antalarminIBA 09/2005
1	Estrogens (Estrogen)FDA Link 09/2005
1	sauvagineIBA 07/2005
1	UrocortinsIBA 10/2004
1	6- cyclopropylmethyl- 2- (2,4- dichlorophenyl)- 7- ethyl- 4- methyl- 7,8- dihydro- 6H- 1,3,6,8a- tetraazaacenaphthyleneIBA 09/2003
1	Atropine FDA LinkGeneric 05/2002

Therapy/Procedure

1	High-Protein Diet 10/2017